To date, there is little attention paid to the intrinsic causation between the estrogen-driven physiological downregulation of Ephx2 gene/sEH and female-susceptibility to be pulmonary hypertensive, a topic that is being investigated in our laboratories. The gene discussed is EPHX2; the disease is pulmonary arterial hypertension.